USA – FDA may authorize convalescent plasma for COVID-19

Antibody-rich blood plasma would be one of the first coronavirus treatments to receive approval, which could pave way for wider use

Sources familiar with the issue say FDA may soon make a decision to authorize emergency use of blood plasma from recovered COVID-19 patients for treating those infected with the disease. Some physicians and hospitals already treat hospitalized COVID-19 patients with convalescent plasma under compassionate use and as part of studies.

Sources familiar with the issue say FDA may soon make a decision to authorize emergency use of blood plasma from recovered COVID-19 patients for treating those infected with the disease. Some physicians and hospitals already treat hospitalized COVID-19 patients with convalescent plasma under compassionate use and as part of studies…